Alvotech company information, Employees & Contact Information

Alvotech Announces Changes in Global Business Development and Commercial Operations Team GlobeNewswire

Alvotech (NASDAQ: ALVO) names commercial and BD leads; CCO Anil Okay to lead Adalvo Stock Titan

Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT Yahoo Finance

Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York Yahoo Finance

Alvotech: EMA Accepts MAA for AVT23, biosimilar to Xolair | ALVO Stock News Stock Titan

Alvotech’s Lenders Lower Interest on Senior Secured Term Loan Facility Yahoo Finance

Alvotech Announces Marketing Approval in Japan of Three New Biosimilars GlobeNewswire

Alvotech appoints Patrik Ling as VP of Investor Relations Scandinavia Yahoo Finance

Alvotech to Release First Half 2025 Financial Results on August 13, Conference Call Scheduled for August 14 Quiver Quantitative

Alvotech to Present at Morgan Stanley 23rd Annual Global Healthcare Conference in New York Quiver Quantitative

Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update GlobeNewswire

European Medicines Agency Recommends Marketing Authorization of AVT03, Alvotech’s Proposed Biosimilar to Prolia® and Xgeva® GlobeNewswire

Alvotech to Release First Half 2025 Financial Results and Host Conference Call Quiver Quantitative

European Medicines Agency Recommends Marketing Approval of GlobeNewswire

Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea® Yahoo Finance

Alvotech and Advanz Pharma Enter into European Supply and GlobeNewswire

First-Ever Golimumab Biosimilar Among Three New Approvals: Alvotech Expands Japan Portfolio Stock Titan

Alvotech Publishes Prospectus in Connection with its Listing on Nasdaq Stockholm Yahoo Finance

Alvotech Announces the Outcome of the Offering in Connection with the Company’s Listing on Nasdaq Stockholm Yahoo Finance

Trading in Alvotech’s Shares on Nasdaq Stockholm Commences Today Yahoo Finance

Major Osteoporosis Treatment Breakthrough: Alvotech's Biosimilar for Prolia/Xgeva Gets Key EU Approval Stock Titan

Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab) Business Wire

Alvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Three Additional Biosimilars in Europe GlobeNewswire

Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab) GlobeNewswire

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab) Yahoo Finance

Trading in Alvotech’s Shares on Nasdaq Stockholm Commences Today GlobeNewswire

Alvotech Expands Global Manufacturing Network: Strategic Acquisition Powers Launch of 3 New Biosimilars Stock Titan

Alvotech Acquires Xbrane’s R&D Operations in Sweden and GlobeNewswire

Alvotech and Dr. Reddy’s Announce FDA acceptance of GlobeNewswire

Skipulagsbreytingar á viðskiptasviði Alvotech GlobeNewswire

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept) Yahoo Finance

Alvotech and Dr. Reddy’s Announce FDA Acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva® Business Wire

Alvotech Expands Biosimilar Pipeline: Strategic $29M Acquisition Adds Cimzia Competitor Stock Titan

Teva Pharmaceuticals and Alvotech Announce U.S. Launch of SELARSDI™ Biosimilar for Multiple Indications Quiver Quantitative

REG-Alvotech Appoints DNB Carnegie as Liquidity Provider on Nasdaq Stockholm TradingView

Alvotech Announces Marketing Approval in Japan of Three New Biosimilars The Manila Times

Lyfjastofnun Evrópu mælir með leyfi til markaðssetningar á GlobeNewswire

Alvotech’s Position In The Coming Biosimilar Gold Rush (NASDAQ:ALVO) Seeking Alpha

Markaðsleyfi veitt í Japan fyrir þrjár nýjar líftæknilyfjahliðstæður frá Alvotech GlobeNewswire

Alvotech Announces Strategic Refinancing Agreement Yahoo Finance

Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference GlobeNewswire

Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab) Yahoo Finance

Alvotech and STADA add to Strategic Alliance through Denosumab Partnership GlobeNewswire

Alvotech and Dr. Reddy’s enter into collaboration for GlobeNewswire

Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S. GlobeNewswire

Alvotech Enters into Exclusive Licensing Agreement with GlobeNewswire

Alvotech, a Global Pureplay Biosimilars Company, to Debut on Nasdaq Under the Ticker ALVO on June 16 Business Wire

Alvotech Announces Changes to its Leadership Team GlobeNewswire

Alvotech Issues New Shares to Holders of Convertible Bonds NTB Kommunikasjon

STADA and Alvotech launch Uzpruvo, the first approved ustekinumab biosimilar to Stelara, across Europe NTB Kommunikasjon

Alvotech Reports Update on Initial AVT02 Biologics License Application GlobeNewswire

, Providing Access to Previously Unavailable Versions in Canada Business Wire

Alvotech Resolves U.S. Patent and Trade Secret Disputes with AbbVie, Securing U.S. Rights for Alvotech’s Proposed High-Concentration Biosimilar (AVT02) for Humira ® NTB Kommunikasjon